ContextLogic Inc. (LOGC)

OTCMKTS · Delayed Price · Currency is USD
6.94
+0.26 (3.89%)
Jun 5, 2025, 4:00 PM EDT
28.04%
Market Cap 188.64M
Revenue (ttm) 7.00M
Net Income (ttm) -20.00M
Shares Out 26.68M
EPS (ttm) -0.76
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,666,922
Average Volume 918,694
Open 6.60
Previous Close 6.68
Day's Range 6.54 - 6.97
52-Week Range 4.92 - 9.34
Beta 2.03
RSI 44.06
Earnings Date Aug 8, 2025

About ContextLogic

ContextLogic Inc. does not have significant operations. It focuses on identifying, evaluating, and executing strategic opportunities. Previously, it was engaged in the marketplace and logistics business operations. ContextLogic Inc. was incorporated in 2010 and is headquartered in Oakland, California. [Read more]

Industry Internet Retail
Founded 2010
Employees 8
Stock Exchange OTCMKTS
Ticker Symbol LOGC
Full Company Profile

Financial Performance

In 2024, ContextLogic's revenue was $43.00 million, a decrease of -85.02% compared to the previous year's $287.00 million. Losses were -$75.00 million, -76.34% less than in 2023.

Financial Statements

News

ContextLogic Inc. to Commence Trading on the OTC Markets and Delist from Nasdaq

OAKLAND, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC) (“ContextLogic,” the “Company,” “we” or “our”) today announced its intention to voluntarily delist from The Nasdaq Gl...

7 days ago - GlobeNewsWire

ContextLogic Inc (LOGC) Q1 2025 Earnings Call Highlights: Strategic Investments Propel Growth ...

ContextLogic Inc (LOGC) Q1 2025 Earnings Call Highlights: Strategic Investments Propel Growth Prospects

27 days ago - GuruFocus

ContextLogic Inc. Reports First-Quarter 2025 Financial Results

OAKLAND, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC) (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the quarter ended March 31, 2...

4 weeks ago - GlobeNewsWire

ContextLogic Q1 2025 Earnings Preview

4 weeks ago - Seeking Alpha

An Overview of ContextLogic's Earnings

ContextLogic (NASDAQ: LOGC) is gearing up to announce its quarterly earnings on Friday, 2025-05-09. Here's a quick overview of what investors should know before the release. Analysts are estimating t...

4 weeks ago - Benzinga

ContextLogic to Announce First Quarter 2025 Results on May 9, 2025

OAKLAND, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC), (“ContextLogic” or the “Company”) today announced it will report its first quarter 2025 financial results after the ...

4 weeks ago - GlobeNewsWire

ContextLogic Inc. (WISH) Q4 2024 Earnings Conference Call Transcript

ContextLogic Inc. (WISH) Q4 2024 Earnings Conference Call March 12, 2025 5:00 PM ET Company Participants Ted Goldthorpe - Chairman Rishi Bajaj - CEO Conference Call Participants Operator Good afternoo...

3 months ago - Seeking Alpha

ContextLogic Inc. Reports Fourth-Quarter and Fiscal Year 2024 Financial Results

OAKLAND, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC) (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the quarter and fiscal year...

3 months ago - GlobeNewsWire

ContextLogic to Announce Fourth Quarter and Full Year 2024 Results and Provide Strategic Update on March 12, 2025

OAKLAND, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC), (“ContextLogic,” the “Company,” “we” or “our”) today announced it will report its fourth quarter and full year 202...

3 months ago - GlobeNewsWire

ContextLogic Inc. Reports Third-Quarter 2024 Financial Results

OAKLAND, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC), (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the quarter and nine months...

7 months ago - GlobeNewsWire

ContextLogic Inc. Reports Second-Quarter Financial Results

OAKLAND, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC), (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the quarter and six months ...

10 months ago - GlobeNewsWire

Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® Therapeutics

WILMINGTON, Del.--(BUSINESS WIRE)--Alexion, AstraZeneca Rare Disease, today announced the completion of its acquisition of LogicBio® Therapeutics, Inc. (NASDAQ: LOGC), a pioneering genomic medicine ...

2 years ago - Business Wire

LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates

- Pre-clinical results published in PLOS ONE demonstrating a single intravenous administration of mLB-001 in neonatal or adult MMA mice correlated with prevention of severe weight loss and mortality w...

2 years ago - PRNewsWire

INVESTOR ALERT: The M&A Class Action Firm Announces the Investigation of LogicBio Therapeutics, Inc. - LOGC

NEW YORK , Oct. 3, 2022 /PRNewswire/ -- Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rat...

2 years ago - PRNewsWire

SHAREHOLDER ALERT: Weiss Law Investigates LogicBio Therapeutics, Inc.

NEW YORK , Oct. 3, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of LogicBio Therapeutics, Inc. ("LogicBio" ...

2 years ago - PRNewsWire

Shareholder Alert: Ademi LLP investigates whether LogicBio® Therapeutics, Inc. has obtained a Fair Price in its transaction with AstraZeneca

MILWAUKEE , Oct. 3, 2022 /PRNewswire/ -- Ademi LLP is investigating LogicBio (NASDAQ: LOGC) for possible breaches of fiduciary duty and other violations of law in its transaction with AstraZeneca.  Cl...

2 years ago - PRNewsWire

LogicBio's stock skyrockets after buyout bid for a 667% premium

Shares of LogicBio Therapeutics Inc. LOGC, +641.32% skyrocketed more than seven-fold (up 643%) in morning trading, to bounce off the previous session's record low, after the genetic medicine company a...

2 years ago - Market Watch

LOGC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LogicBio Therapeutics, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of LogicBio Therapeutics, Inc. (NASDAQ: LOGC) to AstraZeneca Rare Disease for $2.07 per shar...

2 years ago - Business Wire

AstraZeneca pays 660% premium for gene therapy firm LogicBio

Shares of LogicBio Therapeutics skyrocketed on Monday after Britain's AstraZeneca's said it would buy the U.S.-based gene therapy developer at a rare 660% premium for $68 million.

2 years ago - Reuters

Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine

WILMINGTON, Del.--(BUSINESS WIRE)--Alexion, AstraZeneca Rare Disease, today announced that it has entered a definitive agreement to acquire Lexington, Mass.-based LogicBio® Therapeutics, Inc. (NASDAQ:...

2 years ago - Business Wire